Insider Actions for Bio-Techne Corp.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 08/03/2020 |
Julie L. Bushman Director |
89 | Award at $0 per share. | 0 |
| 07/09/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
74 | Disposition at $278.84 per share. | 20,634 |
| 07/09/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
2,746 | Disposition at $278.06 per share. | 763,552 |
| 07/09/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
1,954 | Disposition at $277.28 per share. | 541,805 |
| 07/09/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
400 | Disposition at $276.02 per share. | 110,408 |
| 07/09/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
918 | Disposition at $274.8 per share. | 252,266 |
| 07/09/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
2,042 | Disposition at $273.33 per share. | 558,139 |
| 07/09/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
505 | Disposition at $272.48 per share. | 137,602 |
| 07/09/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
440 | Disposition at $270.97 per share. | 119,226 |
| 07/09/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
9,079 | Derivative/Non-derivative trans. at $108.49 per share. | 984,980 |
| 07/07/2020 |
James T. Hippel Chief Financial Officer |
500 | Disposition at $272.26 per share. | 136,130 |
| 07/07/2020 |
James T. Hippel Chief Financial Officer |
1,663 | Disposition at $271.4 per share. | 451,338 |
| 07/07/2020 |
James T. Hippel Chief Financial Officer |
414 | Disposition at $270.56 per share. | 112,011 |
| 07/07/2020 |
James T. Hippel Chief Financial Officer |
2,577 | Derivative/Non-derivative trans. at $108.49 per share. | 279,578 |
| 07/06/2020 |
James T. Hippel Chief Financial Officer |
1,269 | Disposition at $274.52 per share. | 348,365 |
| 07/06/2020 |
James T. Hippel Chief Financial Officer |
1,934 | Disposition at $273.71 per share. | 529,355 |
| 07/06/2020 |
James T. Hippel Chief Financial Officer |
4,947 | Disposition at $272.34 per share. | 1,347,265 |
| 07/06/2020 |
James T. Hippel Chief Financial Officer |
3,781 | Disposition at $271.53 per share. | 1,026,654 |
| 07/06/2020 |
James T. Hippel Chief Financial Officer |
9,571 | Disposition at $270.45 per share. | 2,588,476 |
| 07/06/2020 |
James T. Hippel Chief Financial Officer |
21,502 | Derivative/Non-derivative trans. at $108.49 per share. | 2,332,751 |
| 05/29/2020 |
Harold J. Wiens Director |
3,985 | Disposition at $260 per share. | 1,036,100 |
| 05/29/2020 |
Norman David Eansor President-Protein Sciences |
709 | Disposition at $264.01 per share. | 187,183 |
| 05/29/2020 |
Norman David Eansor President-Protein Sciences |
2,100 | Disposition at $262.68 per share. | 551,628 |
| 05/29/2020 |
Norman David Eansor President-Protein Sciences |
3,400 | Disposition at $261.74 per share. | 889,916 |
| 05/29/2020 |
Norman David Eansor President-Protein Sciences |
1,700 | Disposition at $260.83 per share. | 443,411 |
| 05/29/2020 |
Harold J. Wiens Director |
3,985 | Derivative/Non-derivative trans. at $101.19 per share. | 403,242 |
| 05/29/2020 |
Norman David Eansor President-Protein Sciences |
7,909 | Derivative/Non-derivative trans. at $108.49 per share. | 858,047 |
| 05/28/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
3,800 | Disposition at $260.38 per share. | 989,444 |
| 05/28/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
2,195 | Disposition at $259.72 per share. | 570,085 |
| 05/28/2020 |
Norman David Eansor President-Protein Sciences |
3,448 | Disposition at $260.19 per share. | 897,135 |
| 05/28/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
1,600 | Derivative/Non-derivative trans. at $94.35 per share. | 150,960 |
| 05/28/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
5,995 | Derivative/Non-derivative trans. at $108.49 per share. | 650,397 |
| 05/28/2020 |
Norman David Eansor President-Protein Sciences |
3,448 | Derivative/Non-derivative trans. at $108.49 per share. | 374,073 |
| 05/26/2020 |
Charles R. Kummeth Chief Executive Officer; Director |
13,018 | Derivative/Non-derivative trans. at $266.4 per share. | 3,467,995 |
| 05/26/2020 |
Charles R. Kummeth Chief Executive Officer; Director |
21,159 | Derivative/Non-derivative trans. at $86.25 per share. | 1,824,963 |
| 05/22/2020 |
Harold J. Wiens Director |
378 | Gift at $0 per share. | 0 |
| 05/22/2020 |
Norman David Eansor President-Protein Sciences |
4,924 | Disposition at $268.41 per share. | 1,321,650 |
| 05/22/2020 |
Norman David Eansor President-Protein Sciences |
7,676 | Disposition at $267.62 per share. | 2,054,251 |
| 05/22/2020 |
Norman David Eansor President-Protein Sciences |
8,637 | Derivative/Non-derivative trans. at $108.49 per share. | 937,028 |
| 05/22/2020 |
Norman David Eansor President-Protein Sciences |
3,963 | Derivative/Non-derivative trans. at $94.35 per share. | 373,909 |
| 05/21/2020 |
Robert V. Baumgartner Director |
125 | Disposition at $267.94 per share. | 33,492 |
| 05/21/2020 |
Robert V. Baumgartner Director |
1,974 | Disposition at $267.32 per share. | 527,689 |
| 05/21/2020 |
Robert V. Baumgartner Director |
1,601 | Disposition at $266.07 per share. | 425,978 |
| 05/21/2020 |
Robert V. Baumgartner Director |
1,300 | Disposition at $265.35 per share. | 344,955 |
| 05/21/2020 |
Norman David Eansor President-Protein Sciences |
900 | Disposition at $268.88 per share. | 241,992 |
| 05/21/2020 |
Norman David Eansor President-Protein Sciences |
10,137 | Disposition at $267.37 per share. | 2,710,329 |
| 05/21/2020 |
Robert V. Baumgartner Director |
5,000 | Derivative/Non-derivative trans. at $70.35 per share. | 351,750 |
| 05/21/2020 |
Norman David Eansor President-Protein Sciences |
11,037 | Derivative/Non-derivative trans. at $94.35 per share. | 1,041,340 |
| 05/06/2020 |
Harold J. Wiens Director |
4,260 | Disposition at $250 per share. | 1,065,000 |
| 05/06/2020 |
Harold J. Wiens Director |
4,260 | Derivative/Non-derivative trans. at $87.34 per share. | 372,068 |
